Related Experiment Videos
Introduction to a structural basis for renal and vascular complications in diabetes and hypertension
1Unit for Metabolic Medicine, Guy's Medical School, London, UK.
Insights
Understanding the structural basis of cardiovascular and renal complications in diabetes and hypertension is key for developing targeted interventions. Angiotensin converting enzyme inhibitors may offer preventive strategies by targeting key processes contributing to vascular damage.
Area of Science:
- Cardiovascular and Renal Medicine
- Diabetology
- Hypertension Research
Background:
- Vascular damage in diabetes and hypertension involves cell hypertrophy/hyperplasia and excessive extracellular matrix deposition.
- Increased activity of cell growth markers like Na(+)-H+ exchange is observed in diabetic renal disease and essential hypertension.
- Insulin resistance is a common factor in hypertension and diabetes, potentially exacerbating renal and cardiovascular damage.
Purpose of the Study:
- To elucidate the structural underpinnings of cardiorenal complications in diabetes and hypertension.
- To identify potential therapeutic targets for preventing vascular damage.
- To explore the role of insulin resistance and genetic predisposition in the diabetic cardiorenal syndrome.
Main Methods:
- Analysis of cellular and extracellular matrix changes in vascular tissues.
- Assessment of cell growth/proliferation markers, including Na(+)-H+ exchange.
- Evaluation of risk factor clustering and familial predisposition in affected patient subsets.
Main Results:
- Vascular damage characterized by cellular hypertrophy/hyperplasia and excessive extracellular matrix deposition.
- Elevated Na(+)-H+ exchange activity in diabetic renal disease and essential hypertension.
- Clustering of cardiovascular risk factors (dyslipidemia, left ventricular hypertrophy, hypertension) in diabetic patients with renal disease.
Conclusions:
- Angiotensin converting enzyme inhibitors show potential for preventive strategies in managing diabetes and hypertension.
- Therapeutic agents targeting hemodynamic, growth, and insulin sensitivity processes can mitigate vascular damage.
- Familial predisposition may underlie susceptibility to the diabetic cardiorenal syndrome, highlighting the need for integrated management approaches.
Background:
An understanding of the structural basis for cardiovascular and renal complications in diabetes and hypertension is critical to design-focused intervention strategies.
Hypothesis:
The processes leading to vascular damage in the kidney and in the arteries in diabetes and hypertension appear to be characterized by hypertrophic/hyperplastic changes in a number of cell types (such as smooth muscle cells, fibroblasts, mesangial cells) and by excessive deposition of extracellular matrix material. Markers of cell growth/proliferation, such as Na(+)-H+ exchange, show increased activity in diabetic patients with renal disease and in patients with essential hypertension. Insulin resistance is a feature of arterial hypertension and diabetes and may contribute to renal and cardiovascular damage in these patients. A number of risk factors for cardiovascular disease cluster in the subset of diabetic patients prone to renal disease. These include dyslipidaemia, left ventricular hypertrophy and hypertension. It is postulated that a familial predisposition to renal and cardiovascular disease is the underlying reason for the susceptibility to the diabetic cardiorenal syndrome.
Conclusion:
In the management of diabetes and hypertension, it may prove possible to instigate preventive strategies by using therapeutic agents such as angiotensin converting enzyme inhibitors, which have the potential to interfere with the haemodynamic, growth and insulin sensitivity processes that contribute to vascular damage.